NCT04285099

Brief Summary

We aim to confirm the effect for FOG by changing the frequency through the dual-system approach in PD patients after STN-DBS.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Mar 2020

Shorter than P25 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 26, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

March 1, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2021

Completed
Last Updated

February 26, 2020

Status Verified

February 1, 2020

Enrollment Period

12 months

First QC Date

February 24, 2020

Last Update Submit

February 24, 2020

Conditions

Keywords

Parkinson Disease, Freezing of Gait, Deep Brain Stimulation

Outcome Measures

Primary Outcomes (1)

  • Stimulation frequency ratio in 4 weeks

    Proportion of two frequencies in 4 weeks

    4 weeks

Secondary Outcomes (5)

  • Comparison of Movement Disorder Society Unified Parkinson's Disease Rating Scale Part I score in 130 and 60Hz at the fourth week

    4 weeks

  • Comparison of Movement Disorder Society Unified Parkinson's Disease Rating Scale Part II score in 130 and 60Hz at the fourth week

    4 weeks

  • Comparison of Movement Disorder Society Unified Parkinson's Disease Rating Scale Part IV score in 130 and 60Hz at the fourth week

    4 weeks

  • Comparison of Freezing of Gait Questionnaire score in 130 and 60Hz at the fourth week

    4 weeks

  • Comparison of Parkinson's Disease Questionnaire-39 score in 130 and 60Hz at the fourth week

    4 weeks

Study Arms (2)

PD patients with FOG after STN-DBS[A]

EXPERIMENTAL

Initially started by A setting

Device: Application of dual system in frequency A

PD patients with FOG after STN-DBS[B]

EXPERIMENTAL

Initially started by B setting

Device: Application of dual system in frequency B

Interventions

The investigators set two values of frequency (130, 60Hz) in IPG and allow the patients to change the frequencies freely using the patient controller. Technician randomly sets 130 Hz, 60HZ to A or B.

PD patients with FOG after STN-DBS[A]

The investigators set two values of frequency (130, 60Hz) in IPG and allow the patients to change the frequencies freely using the patient controller. Technician randomly sets 130 Hz, 60HZ to A or B.

PD patients with FOG after STN-DBS[B]

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with PD who are aged 30 years or older
  • patients with bilateral STN-DBS
  • patients who have a FOG at their med "off" state in outpatient clinic or hospitalization, or UPDRS part II FOG subscore above 1

You may not qualify if:

  • patients without FOG
  • patients who have undergone DBS
  • patients who have had previous brain surgery
  • patients who have undergone reoperation of DBS
  • patients who underwent unilateral DBS
  • patients with cognitive impairment (MMSE \<18)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beom S Jeon

Seoul, South Korea

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Because our study is a double-blinded trial within one group, participant and investigator do not know whether the frequency is 130Hz or 60Hz.
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 24, 2020

First Posted

February 26, 2020

Study Start

March 1, 2020

Primary Completion

February 28, 2021

Study Completion

February 28, 2021

Last Updated

February 26, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations